Category: Drug safety and pharmacovigilance
This category dedicated to the topics of drug safety and pharmacovigilance, with several subcategories available for exploration. Feel free to browse the various subcategories according to your interests.
-
Quality Management System
In this blog, you will discover essential insights for enhancing your company’s quality, guided by the principles of GVP (Good Pharmacovigilance Practice). It contains a concise summary of critical information derived from GVP that is imperative for your knowledge.
-
Causality: Known by Three Distinct Names
This blog covers: Introduction Causality is a well-known concept, and in pharmacovigilance, its assessment is fundamental—case processing simply cannot exist without it. However, within the pharmacovigilance domain, causality is often referred to using three distinct terms. If you’re experienced in the field, you’ve likely come across them, but for beginners, these variations might be unfamiliar.…
-
Unveiling Country Identifiers: Code Listing
This blog showcases a comprehensive list featuring alpha-2 and alpha-3 country codes, providing complete identification for each country. While it may seem somewhat distant within our niche, it remains relevant to the book-in process.
-
📝 Decoding Personal Data in Pharmacovigilance Reporting
In this comprehensive blog, you’ll learn everything about handling personal data within pharmacovigilance reporting, along with crucial insights. Stay tuned for more updates!
-
㊙ Solicited Reports vs Unsolicited Reports: Key Differences
This blog provides specific information on: Introduction In this write-up, you will have clarity from: Many people believe in a wrong way that solicited and unsolicited refer to the sources of reports, but that is not the case. Here, you will find detailed explanations to help you understand these concepts. Definitions Solicited Reports: These reports…
-
𒌐 CAPA Cases in Pharmacovigilance: An Overview
In this detailed blog, we explore into CAPA cases, their workflow, and their significance within pharmacovigilance. Explore further to gain a deeper understanding of how to effectively manage CAPA within this context.
-
❇ Thalidomide incident and pharmaceutical industry
Welcome to our comprehensive blog where we delve into the transformative impact of thalidomide and its lasting influence on the cost burden of drugs in our society today. Gain a deep understanding of how the incident reshaped the way we approach drug development, testing, and regulation.
-
🥶 Adverse Drug Reactions vs Adverse Event: The differences
In this blog, we address the common confusion between adverse reactions and adverse events. We aim to clarify the distinction between these terms that often perplex many individuals. If you are still uncertain about the difference, this blog provides the perfect opportunity to gain clarity and enhance your understanding.
